GSK Korea sponsored symposia for Avandamet

Published: 2003-03-12 06:56:00

Updated: 2003-03-12 06:56:00

GSK Korea said it has sponsored symposia in commemoration of launching in Korea of Avandamet tablet (rosiglitazone maleate + metformin), type 2 diabetes medication, from next month.

For more convenient prescription for patients Avandamet tablet (2mg/500mg, 4mg/500mg) is the first and only comb...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK